 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/20/2017 |
$2.45 |
$2.50 |
$2.45 |
$2.48 |
217.40K | | 07/21/2017 |
$2.48 |
$2.50 |
$2.40 |
$2.42 |
234.40K | | 07/24/2017 |
$2.45 |
$2.45 |
$2.35 |
$2.45 |
281.70K | | 07/25/2017 |
$2.45 |
$2.48 |
$2.35 |
$2.40 |
344.20K | | 07/26/2017 |
$2.45 |
$2.45 |
$2.35 |
$2.38 |
215.90K |
|
|
| ARCA biopharma is a biopharmaceutical company focused on developing genetically-targeted therapies for cardiovascular diseases. Co.'s key product candidate, Gencaro™ (bucindolol hydrochloride), is a pharmacological beta-blocker and mild vasodilator that Co. is evaluating in a clinical trial for the treatment of atrial fibrillation in patients with heart failure with reduced left ventricular ejection fraction. Co. also has pharmacogenetic and other patent rights to drug candidates targeting cardiovascular disease, oncology and other therapeutic areas including rNAPc2, a potential therapy for the disease syndrome caused by infection from hemorrhagic fever viruses and other pathogens. |
|
|
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on July 20, 2017, ABIO opened at $2.45, traded as high as $2.50 and as low as $2.45, and closed at $2.48. Trading volume was a total of 217.40K shares. On July 21, 2017, ABIO opened at $2.48, traded as high as $2.50 and as low as $2.40, and closed at $2.42. Trading volume was a total of 234.40K shares. On July 24, 2017, ABIO opened at $2.45, traded as high as $2.45 and as low as $2.35, and closed at $2.45. Trading volume was a total of 281.70K shares. On July 25, 2017, ABIO opened at $2.45, traded as high as $2.48 and as low as $2.35, and closed at $2.40. Trading volume was a total of 344.20K shares. On July 26, 2017, ABIO opened at $2.45, traded as high as $2.45 and as low as $2.35, and closed at $2.38. Trading volume was a total of 215.90K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/27/2007 |
|
| End date: |
07/26/2017 |
|
| Start price/share: |
$2,049.60 |
|
| End price/share: |
$2.38 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.88% |
|
| Average Annual Total Return: |
-49.11% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11.61 |
|
| Years: |
10.01 |
|
|
|
| Date |
Close |
| 07/20/2017 | $2.48 | | 07/21/2017 | $2.42 | | 07/24/2017 | $2.45 | | 07/25/2017 | $2.40 | | 07/26/2017 | $2.38 |
|
|
